Notes - Significant Accounting Policies For Preparation Of Semi-Annual Consolidated Financial Statements

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7252445

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements
Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements
Disclosure of scope of consolidation
Number of consolidated subsidiaries and names of major consolidated subsidiaries

(1) 連結子会社数  3社  キッセイ商事㈱、キッセイコムテック㈱、ハシバテクノス㈱

Number of consolidated subsidiaries
3 xbrli:pure
Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation

(2) 非連結子会社  1社  KISSEI AMERICA, INC.

(連結の範囲から除いた理由)

非連結子会社は小規模であり、総資産、売上高、当期純損益(持分に見合う額)及び利益剰余金(持分に見合う額)等は、いずれも連結財務諸表に重要な影響を及ぼしていないためです。

Disclosure about application of equity method
Names of major unconsolidated subsidiaries and associates not accounted for using equity method and reasons for this treatment

2.持分法の適用に関する事項

非連結子会社は、当期純損益及び利益剰余金等に及ぼす影響が軽微であり、重要性がないため、持分法の適用から除外しています。

Disclosure about fiscal years, etc. of consolidated subsidiaries

3.連結子会社の事業年度等に関する事項

連結子会社の事業年度末日と連結決算日は一致しています。

Disclosure of accounting policies
Disclosure of accounting policies

Talk to a Data Expert

Have a question? We'll get back to you promptly.